Most PhD students decide to do a postdoc the same way they decided to go to graduate school: because it was the obvious next step, everyone around them was doing it, and no one ever explicitly made the case for an alternative. That is not a decision. It is a default.
A postdoc can be the right move. It can also be a three-to-five year detour that costs you six figures in foregone salary and delays your career without meaningfully improving it. The difference depends on what you want and whether a postdoc actually gets you there. This post gives you the framework to figure out which situation you are in.
The Numbers You Should Know Before You Decide
Start with the financial reality. The NIH NRSA Year 0 postdoc stipend for FY2025 is $62,652 per year, and most institutional postdoc positions are benchmarked to NRSA levels or close to them. The NIH has signaled a target of $70,000 as a minimum over the next few years, but that raise has not yet materialized as a universal floor.
A PhD entering industry as a Scientist I or Associate Scientist in 2026 earns a median of roughly $106,000 to $128,000 per year, depending on location and discipline. In Boston or San Francisco, starting salaries for PhDs at well-funded biotech companies frequently reach $130,000 to $145,000 before equity and bonus.
The arithmetic is not subtle. A three-year postdoc at the NRSA stipend level costs you roughly $130,000 to $200,000 in foregone salary compared to taking an industry position directly after your PhD, before accounting for retirement contributions, equity vesting, or career progression. A five-year postdoc at a well-funded institution with a higher stipend might narrow that gap somewhat, but it does not close it.
This is not an argument against postdocs. It is an argument for making the decision with accurate numbers in hand rather than vague assumptions that the gap is small.
When a Postdoc Is Genuinely Worth Doing
A postdoc is worth doing when it gives you something you need that you cannot get another way, and when you have a specific plan for how the training will translate into the role you want.
You need it for academic faculty positions. If a tenure-track faculty position at a research university is your goal, a postdoc is nearly always required. Hiring committees at R1 institutions expect three to six years of independent postdoctoral research, a strong publication record from that period, and evidence that you can run a lab. There is essentially no path around this, and you should go in knowing that. What you should scrutinize carefully is the quality of the position: the PI’s track record of placing postdocs into faculty roles, the independence you will have, the publication culture of the lab, and the funding stability. Karen Kelsky’s The Professor Is In is the most practical book available on what faculty hiring committees actually look for — worth reading before you commit to the academic track, not after.
You need to switch fields in a meaningful way. A postdoc is one of the few legitimate mechanisms for making a significant scientific pivot. If you did a PhD in structural biology and want to move into cancer immunology, or if you worked on a model organism that is not well-represented in the biotech pipeline, a postdoc in the new area gives you the publications and credibility to make that transition. This rationale is real and valid, but it requires honest self-assessment: is the pivot necessary for the roles you want, or are you using it as a rationalization for staying in an environment you are comfortable in?
You are targeting industry roles that value postdoc training. Some industry positions, particularly in platforms focused on target biology, disease mechanisms, or mechanistic pharmacology at large pharma companies, do give preference to candidates with postdoc training. These are typically more senior discovery biology roles rather than entry-level scientist positions. If you are targeting a role like this and the job descriptions you are looking at consistently list postdoc experience as preferred, the signal is real.
You have a concrete offer from a lab with a clear track record. The quality of the postdoc matters enormously. A two-year position in a high-profile lab with a PI who actively invests in their trainees, regular senior author papers, and a network that opens doors is categorically different from a four-year position in a lab that perpetually renews your contract while the PI delays your independent project.
When a Postdoc Is the Wrong Move
You want an industry role and have no specific gap to fill. The most common mistake is doing a postdoc as a credential for industry when the industry roles you actually want do not require it. Entry-level to mid-level scientist positions at biotech companies hire directly from PhD programs constantly. A postdoc adds time and a publications story, but it does not add much that a well-executed industry job search cannot achieve on its own. If you are doing a postdoc primarily to feel more competitive for industry, be honest about whether the data from your own job search supports that belief.
You are avoiding a difficult decision. A postdoc can be a way of extending the period of structured academic life when the alternatives feel unclear or risky. This is an understandable impulse, but spending three years on it is expensive. If the honest answer to “why a postdoc?” is “I’m not sure what else to do,” that is a reason to spend three months doing serious career exploration, not three years in a lab.
Your target PI has a poor track record of placing trainees. Before accepting any postdoc offer, look at where the last five to ten trainees from that lab ended up. Not where the PI says they ended up: look them up on LinkedIn and look at actual job titles and timelines. If the pattern is long postdoc tenure with unclear exits, that is a data point about the lab culture. A PI who is enthusiastic about your project but has not placed postdocs into good positions in years is a risk.
You are already past five years post-PhD. The window in which postdoc training provides a clear career benefit is not unlimited. Industry hiring managers generally view postdoc experience favorably when it represents a distinct, purposeful training period. A seven-year postdoc raises questions about independence and productivity rather than answering them. If you are approaching the end of a postdoc and wondering whether to extend, the default answer should be no unless you have a specific, achievable milestone remaining.
The Variables Most People Underweight
Time is the primary cost, not salary. The salary gap is significant, but the deeper cost is career trajectory. Starting an industry career at thirty-five versus thirty is a real difference in seniority, network depth, and compounded career capital. This is especially true in biotech, where early career momentum matters more than in large pharma.
Not all postdoc positions are equivalent, and most people do not negotiate them well enough. You can negotiate a postdoc offer: stipend, start date, resource commitments, the scope of your independent project, and authorship expectations. Most trainees do not negotiate at all, treating the offer as fixed. It is not.
The job market in 2026 remains selective. Job postings in life science dropped roughly 20% year-over-year in early 2025 and applications surged over 90%, according to industry tracking data from IntuitionLabs. As of early 2026, the market is recovering but cautiously. This means that the industry alternative to a postdoc is harder than it was in 2021 or 2022, which is a legitimate reason to consider using a postdoc period strategically. It is not a reason to accept any postdoc offer that comes along.
Your publication record from your PhD matters more than you think. Candidates with a strong first-author paper from their PhD program are more competitive for both industry positions and strong postdoc offers than candidates without one. If you are considering extending your PhD time to finish a paper before leaving, that calculation is usually worth doing.
Questions to Ask Before Accepting
Before accepting any postdoc position, get clear answers to these:
Where did your last five postdocs go after leaving the lab, and what is their current role? A PI who cannot or will not answer this question specifically is telling you something.
What is my independent project, and what does success look like at twelve months? If the answer is vague, the project does not exist yet.
What is the lab’s funding situation, and what is the realistic timeline for renewal? A lab whose primary grant is up for renewal in year two of your postdoc is a real risk.
What is the expected publication output, and what is your authorship policy for collaborative projects? Ambiguity here leads to disputes later.
What is your plan for supporting my transition out of the lab, whether that is faculty applications, industry networking, or both? A PI who has never thought about this is unlikely to start on your behalf.
Common Mistakes
Accepting the first offer you receive because it is easier than continuing to look. Postdoc offers have real timelines, but they are rarely as hard as they feel in the moment.
Doing a second postdoc because the first one did not go well. A second postdoc occasionally makes sense after a very short first one, but it is usually a sign that the underlying career question has still not been answered.
Treating the postdoc as a passive period. The researchers who benefit most from postdocs treat them as active career-building phases: they build external collaborations, present at conferences, take on mentorship responsibilities, and start their professional network early rather than at the end.
Assuming that more time in the lab solves the problem. If your first-author paper is not coming together at year two of a postdoc, adding a year three often does not fix the underlying issue and delays the decision point further.
The Bottom Line
Do a postdoc if you have a specific goal that requires it, a concrete plan for how the position advances that goal, and a realistic assessment of the PI’s track record with trainees. Faculty track requires it. A meaningful field switch often justifies it. Specific senior discovery biology roles in industry may benefit from it.
Skip the postdoc if your goal is an industry role that does not require one, if you are using it to defer a decision, or if the offer in front of you does not come from a lab with a credible track record of placing trainees well.
The worst version of this decision is not doing a postdoc or skipping it. It is spending three years in a position without ever having asked these questions.
If you want to go deeper on the practical mechanics of building a scientific career, Peter Feibelman’s A PhD Is Not Enough! covers everything from choosing advisors to negotiating your first position — it’s been required reading for new researchers for decades and holds up well.
For a closer look at one part of this decision, our post on the bioinformatics job market in 2026 covers compensation benchmarks and hiring patterns specifically for computational roles. If you are weighing whether to build computational skills as part of your transition strategy, the wet lab to bioinformatics post walks through what that pivot actually takes.